HUP0402058A2 - Szabályozottan szabaddá váló metformin tabletták és eljárás az előállításukra - Google Patents

Szabályozottan szabaddá váló metformin tabletták és eljárás az előállításukra

Info

Publication number
HUP0402058A2
HUP0402058A2 HU0402058A HUP0402058A HUP0402058A2 HU P0402058 A2 HUP0402058 A2 HU P0402058A2 HU 0402058 A HU0402058 A HU 0402058A HU P0402058 A HUP0402058 A HU P0402058A HU P0402058 A2 HUP0402058 A2 HU P0402058A2
Authority
HU
Hungary
Prior art keywords
metformin
preparation
controlled release
release tablets
controlled
Prior art date
Application number
HU0402058A
Other languages
English (en)
Inventor
Manish Chawla
Rajeev S. Raghuvanshi
Ashok Rampal
Original Assignee
Ranbaxy Laboratories Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Limited filed Critical Ranbaxy Laboratories Limited
Publication of HUP0402058A2 publication Critical patent/HUP0402058A2/hu
Publication of HUP0402058A3 publication Critical patent/HUP0402058A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

A találmány tárgya szabályozottan szabaddá váló metformin és eljáráselőállítására nem ionos és anionos hidrofil polimerek kombinációjával,miközben a teljes hidrofil polimer koncentráció a kompozíció legalább16 tömeg%-a. Ó
HU0402058A 2001-11-06 2002-11-06 Controlled release tablets of metformin and process for their preparation HUP0402058A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1134DE2001 2001-11-06
PCT/IB2002/004647 WO2003039527A1 (en) 2001-11-06 2002-11-06 Controlled release tablets of metformin

Publications (2)

Publication Number Publication Date
HUP0402058A2 true HUP0402058A2 (hu) 2005-02-28
HUP0402058A3 HUP0402058A3 (en) 2006-04-28

Family

ID=11097132

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0402058A HUP0402058A3 (en) 2001-11-06 2002-11-06 Controlled release tablets of metformin and process for their preparation

Country Status (9)

Country Link
US (1) US20030104059A1 (hu)
EP (1) EP1465612A1 (hu)
KR (1) KR20050043765A (hu)
CN (1) CN1700910A (hu)
EA (1) EA200400628A1 (hu)
HU (1) HUP0402058A3 (hu)
PL (1) PL369328A1 (hu)
WO (1) WO2003039527A1 (hu)
ZA (1) ZA200403614B (hu)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003105809A1 (en) * 2002-06-17 2003-12-24 Themis Laboratories Private Limited Multilayer tablets containing thiazolidinedione and biguanides and methods for producing them
WO2004110422A1 (en) * 2003-06-16 2004-12-23 Ranbaxy Laboratories Limited Extended-release tablets of metformin
WO2005092293A1 (en) * 2004-03-22 2005-10-06 Ranbaxy Laboratories Limited Formulations of metformin
EP1814528A2 (en) * 2004-10-08 2007-08-08 Rubicon Research Private Limited Process for making a highly compressible controlled delivery compositions of metformin
CA2780938A1 (en) * 2009-11-13 2011-05-19 Bristol-Myers Squibb Company Reduced mass metformin formulations
US11759441B2 (en) 2011-01-07 2023-09-19 Anji Pharmaceuticals Inc. Biguanide compositions and methods of treating metabolic disorders
US8796338B2 (en) 2011-01-07 2014-08-05 Elcelyx Therapeutics, Inc Biguanide compositions and methods of treating metabolic disorders
US9480663B2 (en) 2011-01-07 2016-11-01 Elcelyx Therapeutics, Inc. Biguanide compositions and methods of treating metabolic disorders
US9211263B2 (en) 2012-01-06 2015-12-15 Elcelyx Therapeutics, Inc. Compositions and methods of treating metabolic disorders
US9572784B2 (en) 2011-01-07 2017-02-21 Elcelyx Therapeutics, Inc. Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk
US11974971B2 (en) 2011-01-07 2024-05-07 Anji Pharmaceuticals Inc. Compositions and methods for treating metabolic disorders
SI2661266T1 (sl) 2011-01-07 2021-01-29 Anji Pharma (Us) Llc Terapije, na osnovi kemosenzoričnih receptorskih ligandov
MX2014008190A (es) 2012-01-06 2015-02-04 Elcelyx Therapeutics Inc Composiciones de biguanida y métodos para tratar transtornos metabólicos.
MX2014008189A (es) 2012-01-06 2015-02-12 Elcelyx Therapeutics Inc Composiciones y metodos para tratar trastornos metabolicos.
WO2016042567A1 (en) * 2014-09-16 2016-03-24 Suresh Pareek Extended release formulation of metformin

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4432757A1 (de) * 1994-09-14 1996-03-21 Boehringer Mannheim Gmbh Pharmazeutische Zubereitung enthaltend Metformin und Verfahren zu deren Herstellung
ES2248908T7 (es) * 1997-06-06 2014-11-24 Depomed, Inc. Formas de dosificación de fármacos por vía oral y retención gástrica para liberación continuada de fármacos altamente solubles
AP1224A (en) * 1998-03-19 2003-11-14 Bristol Myers Squibb Co Biphasic controlled release delivery system for high solubility pharmaceuticals and method.
US6099859A (en) * 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
US6117451A (en) * 1998-08-25 2000-09-12 Pharmalogix, Inc. Direct compression metformin hydrochloride tablets
CA2355860C (en) * 1998-12-23 2010-03-30 Alza Corporation Dosage forms comprising porous particles
WO2002028181A1 (en) * 2000-10-02 2002-04-11 Usv Limited Sustained release pharmaceutical compositions containing metformin and method of its production

Also Published As

Publication number Publication date
CN1700910A (zh) 2005-11-23
KR20050043765A (ko) 2005-05-11
EA200400628A1 (ru) 2004-12-30
HUP0402058A3 (en) 2006-04-28
PL369328A1 (en) 2005-04-18
WO2003039527A1 (en) 2003-05-15
EP1465612A1 (en) 2004-10-13
ZA200403614B (en) 2005-01-14
US20030104059A1 (en) 2003-06-05

Similar Documents

Publication Publication Date Title
HUP0402058A2 (hu) Szabályozottan szabaddá váló metformin tabletták és eljárás az előállításukra
IL221381A (en) 4,2-pyrimidindiamine compounds, their use and processes for their preparation
HUP0401050A2 (hu) Eljárás poliuretán termékek előállítására polimer poliolokból, az eljárással előállított poliuretán termék és polimer poliol készítmény
AU2002326072A1 (en) Fluoro and sulphonylamino containing 3,6-disubstituted azabicyclo (3.1.0) hexane derivatives as muscarinic receptor antagonists
NO20055649L (no) Substituert dihydrokinazolin med antiviale egenskaper
AU2001283963A1 (en) Polysiloxane polymers, method for their production and the use thereof
EA200000584A2 (ru) Твердые фармацевтические композиции с контролируемым высвобождением, получаемые тепловым формованием
HUP0402293A2 (hu) Fexofenadint tartalmazó szájban diszpergálódó tablettakészítmény, bevonatos granulátum és eljárás az előállítására
CY1106944T1 (el) Μεθοδος για την παραγωγη εμφυτευματων μεσω παραγωγης - ανευ διαλυτων - ενος προϊοντος ομογενοποιησης
HUP0204010A2 (hu) Új szertralin-hidroklorid polimorfok, eljárás az előállításukra, az új polimorfokat tartalmazó gyógyszerkészítmények és alkalmazásuk
DE60202958D1 (de) Stabiles polymorph von flibanserin, industrielles verfahren zu dessen herstellung und dessen verwendung zur herstellung von medikamenten
DE60118575D1 (de) Milchsäurepolymer und verfahren zu dessen herstellung
ATE551046T1 (de) Polymere duftkapseln und ihre herstellung
NO20073760L (no) Triazolon-, tetrazolon- og imidazolonderivater for anvendelse som alfa-2C-adrenoreseptorantagonister
BR0212931A (pt) Composição farmacêutica de liberação prolongada contendo metformina
HUP0302427A2 (hu) Emulgeálószerként alkalmazható új amfifil kopolimerek
DE60126332D1 (de) Wärmeformbare feste pharmazeutische zusammensetzung für die kontrollierte freigabe von ivabradin
WO2002060958A3 (en) Functionalized initiators for anionic polymerization, protected funtionalized polymers, deprotected analogues thereof, and methods of making the same
ATE286894T1 (de) 2h-1-benzopyran-derivate, prozesse zu ihrer herstellung und pharmazeutische zusammensetzungen
AU2003268970A8 (en) Aqueous polymer dispersion, preparation and use thereof
ATE309788T1 (de) Mikropartikel mit verbessertem freisetzungsprofil und verfahren zu deren herstellung
WO2006060225A3 (en) Process for asymmetric synthesis of hexahydropyrimido[1,2-a] azepine-2-carboxamides and related compounds
BR0008739A (pt) Composições de liberação controlada debeta-histina
NO20004757D0 (no) Nye dendrimerforbindelser, fremgangsmÕte for fremstilling herav og deres anvendelse som katalysatorer
WO2002072675A3 (en) Predispersions, compositions therefore, and processes for preparing same

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees